asthenia/neoplasms

FIELD OF THE INVENTION This invention relates to a purified and standardized water-soluble fraction obtained from the leaves of a cultivated variety of Phlebodium decumanum, identified as EXPLY-37, to formulations containing it and to their use as nutritional supplements of general application and

TECHNICAL FIELD The invention concerns a method for the management of cancer and treatment cancer comorbidities, including but not limited to cancer-related fatigue, cachexia, anorexia, pain, anemia, asthenia, depression, impaired cognitive function, loss of appetite, muscle weakness, nausea,

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the fields of pharmaceutical chemistry and formulation. More particularly, it concerns the use of an effective amount of riboflavin and amino acids, in any combination, in the alleviation of the

BACKGROUND OF THE INVENTION This invention relates to novel inhibitors of androgen activity, for example to non-steroidal compounds having antagonistic activity on androgen receptor. More particularly, the invention relates to certain non-steroidal compounds having specified side-chains (e.g.

BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies, novel therapies and therapeutic protocols utilizing anti-IL-6 antibodies, and pharmaceutical

The sequence listing in the file named "56256o2006.txt" having a size of 332,224 bytes that was created Sep. 26, 2017 is hereby incorporated by reference in its entirety. BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the